Literature DB >> 7437840

Adverse interaction between nifedipine and beta-blockade.

L H Opie, D A White.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7437840      PMCID： PMC1714859          DOI： 10.1136/bmj.281.6253.1462

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  4 in total

1.  Objective assessment of treatment in severe angina.

Authors:  G D Oakley; K M Fox; H J Dargie; A P Selwyn
Journal:  Br Med J       Date:  1979-06-09

2.  Prinzmetal's variant form of angina pectoris. Re-evaluation of mechanisms.

Authors:  M Endo; I Kanda; S Hosoda; H Hayashi; K Hirosawa; S Konno
Journal:  Circulation       Date:  1975-07       Impact factor: 29.690

3.  Treatment of hypertension with nifedipine, a calcium antagonistic agent.

Authors:  M T Olivari; C Bartorelli; A Polese; C Fiorentini; P Moruzzi; M D Guazzi
Journal:  Circulation       Date:  1979-05       Impact factor: 29.690

4.  Objective assessment of antianginal treatment: a double-blind comparison of propranolol, nifedipine, and their combination.

Authors:  P Lynch; H Dargie; S Krikler; D Krikler
Journal:  Br Med J       Date:  1980-07-19
  4 in total
  31 in total

1.  Kinetics and hemodynamic effects of intravenous nicardipine modified by previous propranolol oral treatment.

Authors:  P Rocha; M Guerret; D David; X Marchand; J C Kahn
Journal:  Cardiovasc Drugs Ther       Date:  1990-12       Impact factor: 3.727

Review 2.  Use of nifedipine in hypertension and Raynaud's phenomenon.

Authors:  W Kiowski; P Erne; F R Bühler
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

3.  Effects of atenolol, slow-release nifedipine, and their combination on respiratory gas exchange and exercise tolerance in stable effort angina.

Authors:  S Wieshammer; M Hetzel; U Barnikel; M Höher; H Seibold; M Kochs; V Hombach
Journal:  Klin Wochenschr       Date:  1991-09-16

Review 4.  Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-09       Impact factor: 9.546

Review 5.  Calcium antagonists--adverse drug interactions.

Authors:  H Reicher-Reiss; H N Neufeld; F X Ebner
Journal:  Cardiovasc Drugs Ther       Date:  1987-12       Impact factor: 3.727

6.  The effects of intravenous nifedipine on cardiac hemodynamics and contractility in patients with coronary artery disease in the presence or absence of beta adrenergic blockade.

Authors:  O Visioli; R Bolognesi; F Cucchini; R Ferrari
Journal:  Cardiovasc Drugs Ther       Date:  1987-12       Impact factor: 3.727

Review 7.  Calcium antagonists in patients with heart failure. A review.

Authors:  H Reicher-Reiss; E Barasch
Journal:  Drugs       Date:  1991-09       Impact factor: 9.546

Review 8.  Calcium channel antagonism and beta blockade in combination--a therapeutic alternative in cardiovascular disorders. A review.

Authors:  J N Lessem; B N Singh
Journal:  Cardiovasc Drugs Ther       Date:  1989-06       Impact factor: 3.727

9.  Aims of combination therapy--improved quality of life or better blood pressure control?

Authors:  D Maclean
Journal:  Drugs       Date:  1988       Impact factor: 9.546

10.  [Calcium antagonists in heart failure?].

Authors:  H Drexler; H Just
Journal:  Klin Wochenschr       Date:  1986-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.